DexCom DXCM Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $199.5M+89.3% | $267.3M+76.2% | $283.8M+111% | $179.8M+25.3% | $105.4M-28.0% | ||
| $67.1M+11.8% | $65.2M+12.8% | $63.6M+15.0% | $63M+20.9% | $60M+14.3% | ||
| $43.3M+26.6% | $35M-19.2% | $45.1M+3.9% | $45.3M+1.3% | $34.2M-12.3% | ||
| $300K+105% | $78.9M— | $118M+1,117% | -$8.9M+39.5% | -$5.8M+86.1% | ||
| -$124.6M-184% | $106.2M+1,335% | —— | $184.6M+646% | $148.9M+2,467% | ||
| $65.2M+1,152% | $17.8M+154% | $33.6M+1,668% | $18.5M+201% | -$6.2M-117% | ||
| $145.1M+15.7% | —— | —— | $234M+224% | $125.4M+14.4% | ||
| -$47.1M-7,750% | $0— | $41.3M+554% | $15.9M— | -$600K+99.0% | ||
| -$51M-209% | $6.9M— | $2.4M— | $22M-61.3% | -$16.5M-44.7% | ||
| $7.3M+170% | -$6.2M+19.5% | -$7.7M— | -$300K+92.3% | $2.7M-15.6% | ||
| $0-100% | $3.1M— | $6M-85.5% | —— | $16.5M+112% | ||
| $0+100% | —— | $82.7M+20,575% | —— | -$4.2M— | ||
| $525.6M+186% | $294M-2.5% | $659.9M+231% | $303M+8.4% | $183.8M-12.1% | ||
| $76.6M-12.0% | $101.9M-18.2% | $80.5M-27.6% | $94.1M+42.4% | $87M+52.9% | ||
| $688.6M+48.9% | $0-100% | $175.9M-42.7% | $608.2M-22.4% | $462.5M-53.4% | ||
| $468.2M-28.0% | $409.6M+1.1% | $466.2M-26.1% | $638.7M-4.2% | $650.2M-42.0% | ||
| $0-100% | -$100K-101% | -$1M+75.0% | $0-100% | $500K+122% | ||
| -$298.5M-398% | $306.6M+201% | $192.8M-8.3% | —— | $100.2M+34.0% | ||
| $12.7M-10.6% | —— | $13.9M-6.1% | —— | $14.2M+6.0% | ||
| $35.8M— | —— | —— | —— | $0— | ||
| -$1.9M-11.8% | -$1.9M-18.8% | -$1.7M-30.8% | -$1.7M-21.4% | -$1.7M+80.5% | ||
| -$25M-300% | -$1.52B-95,038% | -$175M+76.2% | -$1.7M-21.4% | $12.5M+166% | ||
| -$2.8M-222% | $3.8M+134% | $0-100% | $16.5M+1,750% | $2.3M+161% | ||
| $199.3M-33.3% | —— | $676.6M— | $254.2M+189% | $298.8M+4.9% | ||
| —— | $2.85M0.0% | $2.85M0.0% | $2.85M0.0% | $2.85M0.0% | ||
| —— | $23.6M-52.3% | $23.6M-52.3% | $23.6M-52.3% | $23.6M-52.3% | ||
| $0+100% | —— | $82.7M+20,575% | —— | -$4.2M— | ||
| -$47.1M-7,750% | $0— | $41.3M+554% | $15.9M— | -$600K+99.0% | ||
| $1.3M+44.4% | $2.6M-25.7% | $1.5M— | $2.1M— | $900K— | ||
| -$51M-209% | $6.9M— | $2.4M— | $22M-61.3% | -$16.5M-44.7% | ||
| $0-100% | $3.1M— | $6M-85.5% | —— | $16.5M+112% | ||
| $1M-47.4% | $1.7M-10.5% | $1.9M0.0% | $1.8M0.0% | $1.9M0.0% | ||
| $0-100% | -$100K-101% | -$1M+75.0% | $0-100% | $500K+122% | ||
| $1.5M— | $1.2M-98.4% | —— | —— | $0— | ||
| $468.2M-28.0% | $409.6M+1.1% | $466.2M-26.1% | $638.7M-4.2% | $650.2M-42.0% | ||
| -$1.9M-11.8% | -$1.9M-18.8% | -$1.7M-30.8% | -$1.7M-21.4% | -$1.7M+80.5% | ||
| —— | $301.88M— | $301.88M— | $301.88M— | $301.88M— | ||
| $50.4M-12.5% | $16.3M— | —— | —— | $57.6M+41.5% | ||
| $2M+81.8% | —— | —— | $300K-87.5% | $1.1M-85.1% | ||
| $400K— | —— | $2.2M— | $500K-93.4% | $0-100% | ||
| $449M+364% | $192.1M+8.7% | $579.4M+556% | $208.9M-2.1% | $96.8M-36.4% | ||
| $449M+364% | $192.1M+8.7% | $579.4M+556% | $208.9M-2.1% | $96.8M-36.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does DexCom generate?
- DexCom (DXCM) generated $1.8B in operating cash flow over the trailing twelve months.
- What is DexCom's free cash flow?
- After $353.1M of capital expenditures, DexCom's free cash flow was $1.4B over the trailing twelve months, up 148.5% year over year.
- Where does DexCom's cash flow data come from?
- Every line is extracted from DexCom's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
